Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Over-The-Counter Viagra Could Be Coming to a Pharmacy Near You

XTALKS VITALS NEWS

Viagra

Viagra, marketed by Pfizer, has been a blockbuster drug since its launch 20 years ago.

Share this!

March 31, 2017 | by Sarah Hand, M.Sc.

The British Medicines and Healthcare Products Regulatory Agency (MHRA) is looking at making Viagra (sildenafil) available as an over-the-counter (OTC) medication in the UK. While the erectile dysfunction drug is currently only available by prescription, the agency is seeking public comment on the possible change until April 18.

Viagra, marketed by Pfizer, has been a blockbuster drug since its launch 20 years ago. In 2012, sales of the erectile dysfunction drug reached $2 billion, however the launch of generic versions has eroded sales by about $400 million.

In 2013, global pharmaceutical company Actavis, launched generic versions of Viagra in Europe. In the US, patients won’t be able to get a generic form of the drug until late 2017.



One of the drivers behind making Viagra an OTC medication is to discourage people from ordering the drug through online pharmacies, which may or may not be licensed. Since its launch, Viagra has been vulnerable to drug counterfeiters who sell fake versions to men who might be too embarrassed to get a prescription for the drug from their doctors.

“The availability of pharmacist-supplied, non-prescription sildenafil could offer men a new and additional way to access a legitimate, long established, and well-studied treatment for erectile dysfunction,” said Dr. Berkeley Phillips, UK Medical Director, Pfizer. “This could have further benefits as the condition may be an early warning sign of a more serious underlying condition, such as heart disease, which may otherwise go undetected.”

Pfizer pushed to get Viagra reclassified as an OTC drug back in 2008, however the European Medicines Agency (EMA) denied the request due to concerns about supply. If the British regulatory agency approves the decision to offer OTC Viagra in pharmacies, Pfizer will likely continue to provide a branded version by prescription.

“Pharmacy availability of sildenafil tablets would be of value to men who suffer from erectile dysfunction,” said the MHRA document. “Patients can be assessed for suitability by a pharmacist and made aware of the risks, situations where supply is not appropriate and potential interactions with other drugs. The risks of indirect danger arising from missed diagnosis of underlying disease is minimized through the pharmacist using their professional judgement and the checklist to identify patients for whom the product is not suitable, and referring these patients to a doctor.”


Keywords:  OTC Drug, Blockbuster Drug, Prescription


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Kite Pharma Secures FDA Approval for CAR-T Immunotherapy

October 20, 2017 - Kite Pharma’s Yescarta (axicabtagene ciloleucel) has become the second CAR-T immunotherapy to be approved in the US, with an indication in treating adult patients with relapsed or refractory large B-cell lymphoma.

Featured In: Biotech News


Fallopian Tubes Found to be Site of Origin for Most Ovarian Cancers

October 20, 2017 - This year, over 22,000 women will be diagnosed with ovarian cancer but a new study conducted by researchers at Perlmutter Cancer Center at NYU Langone Health suggests that most of these malignancies begin in another part of the reproductive system: the fallopian tubes.

Featured In: Life Science News


Food Companies are Looking for the Next Sriracha

October 19, 2017 - The Sriracha trend might be coming to an end and companies are looking for the next big hot sauce star to feature in their line-up.

Featured In: Food News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Brexit – Separating Fact from Fiction


Evolving Best Practices for Working with Authors of Scientific Publications – Authorship and Beyond


Human Whole-Genome Sequencing in a New Era Defined by the Illumina® HiSeq X® and NovaSeq™ Platforms


Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution


Copyright © 2016-2017 Honeycomb Worldwide Inc.